While dietary supplements are not intended to treat or prevent serious diseases such as cancer, they may play a role as a complementary therapy or nutritional adjunct.
Fucoidan is a kind of polysaccharide mainly derived from brown seaweed species such as Laminaria. Its impact on cellular metabolism and inflammatory response has been widely researched in both in vitro and in vivo experiments.
Hi-Q extracted Oligo Fucoidan (OliFuco®) with advanced technology. With an excellent R&D team, more than 50 international scientific articles were published. Among the articles, over 30 explore carcinogenesis, immunomodulation and inflammation. In one prospective, randomized, double-blind, controlled clinical trial in patients with metastatic colorectal cancer (mCRC), using Low Molecular Weight Fucoidan (Oligo Fucoidan) as an adjunct treatment with anti-cancer drugs significantly improved disease control rate (DCR).
Disclaimer: Hi-Q supplies OliFuco® as a raw material to companies to produce a variety of products. Hi-Q does not make any claims regarding the use of these finished products, and each manufacturer is responsible for ensuring that the claims made for and use of their products comply with the laws and regulations of the locations or countries where their products are sold.